See up to 3 months of XAIR. The 7-day demo opens the 1M and 3M ranges and puts XAIR on your watchlist.
Start 7-day demoLatest XAIR insider trades
About Beyond Air, Inc. (XAIR)
Beyond Air, Inc. files with the SEC under CIK 0001641631 and is classified as surgical and medical instruments and apparatus. We track it alongside the rest of the Health Care sector. It filed a registration statement with the SEC on 21 November 2025 and has not yet priced an offering.
XAIR Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 4 | 23,000 | $62K |
XAIR insider transactions (Form 4)
21925 Form 4 filings on record, the earliest from Oct 2, 2024, newest first.
| Traded | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Yi-Chien Lin - 10% Owner | Open-market purchase | Common Stock | 2,607 | $2.21 | $6K | |
| Yi-Chien Lin - 10% Owner | Open-market purchase | Common Stock | 3,000 | $2.69 footnote F1 | $8K | |
| Yi-Chien Lin - 10% Owner | Open-market purchase | Common Stock | 2,000 | $2.71 footnote F1 | $5K | |
| Yi-Chien Lin - 10% Owner | Open-market purchase | Common Stock | 15,393 | $2.80 footnote F1 | $43K | |
| ||||||
| Robert Scott Goodman - Officer | Open-market purchase | Common Stock | 34,722 | $5.76 | $200K | |
| Robert Scott Goodman - Officer | Open-market purchase | Series A Warrants | 34,722 | - footnote F3 | - | |
| Robert Scott Goodman - Officer | Open-market purchase | Series B Warrants | 34,722 | - footnote F3 | - | |
| ||||||
| Daniel J. Moorhead - Officer | Open-market purchase | Common Stock | 4,340 | $5.76 | $25K | |
| Daniel J. Moorhead - Officer | Open-market purchase | Series A Warrant | 4,340 | - footnote F3 | - | |
| Daniel J. Moorhead - Officer | Open-market purchase | Series B Warrant | 4,340 | - footnote F3 | - | |
| ||||||
| Daniel J. Moorhead - Officer | Grant or award | Stock Option (right to buy) | 70,000 | - | - | |
| Yoori Lee - Director | Derivative | Stock Options (Right to buy) | 2,250 | - footnote F1 | - | |
| Yoori Lee - Director | Grant or award | Stock Options (Right to buy) | 2,250 | - footnote F1 | - | |
| Yoori Lee - Director | Derivative | Stock Options (Right to buy) | 2,000 | - footnote F1 | - | |
| Yoori Lee - Director | Grant or award | Stock Options (Right to buy) | 2,000 | - footnote F1 | - | |
| Yoori Lee - Director | Derivative | Stock Options (Right to buy) | 1,500 | - footnote F1 | - | |
| Yoori Lee - Director | Grant or award | Stock Options (Right to buy) | 1,500 | - footnote F1 | - | |
| Yoori Lee - Director | Derivative | Stock Options (Right to buy) | 1,250 | - footnote F1 | - | |
| Yoori Lee - Director | Derivative | Stock Options (Right to buy) | 1,250 | - footnote F1 | - | |
| Yoori Lee - Director | Derivative | Stock Options (Right to buy) | 1,250 | - footnote F1 | - | |
| Yoori Lee - Director | Grant or award | Stock Options (Right to buy) | 1,250 | - footnote F1 | - | |
| Yoori Lee - Director | Grant or award | Stock Options (Right to buy) | 1,250 | - footnote F1 | - | |
| Yoori Lee - Director | Grant or award | Stock Options (Right to buy) | 1,250 | - footnote F1 | - | |
| Yoori Lee - Director | Derivative | Stock Options (Right to buy) | 750 | - footnote F1 | - | |
| Yoori Lee - Director | Grant or award | Stock Options (Right to buy) | 750 | - footnote F1 | - | |
| Yoori Lee - Director | Derivative | Stock Options (Right to buy) | 3,750 | - footnote F1 | - | |
| Yoori Lee - Director | Grant or award | Stock Options (Right to buy) | 3,750 | - footnote F1 | - | |
| ||||||
| Michael A. Gaul - Officer | Derivative | Stock Options (Right to buy) | 17,500 | - footnote F1 | - | |
| Michael A. Gaul - Officer | Grant or award | Stock Options (Right to buy) | 17,500 | - footnote F1 | - | |
| Michael A. Gaul - Officer | Derivative | Stock Options (Right to buy) | 8,500 | - footnote F1 | - | |
| Michael A. Gaul - Officer | Grant or award | Stock Options (Right to buy) | 8,500 | - footnote F1 | - | |
| Michael A. Gaul - Officer | Derivative | Stock Options (Right to buy) | 3,500 | - footnote F1 | - | |
| Michael A. Gaul - Officer | Grant or award | Stock Options (Right to buy) | 3,500 | - footnote F1 | - | |
| Michael A. Gaul - Officer | Derivative | Stock Options (Right to buy) | 1,250 | - footnote F1 | - | |
| Michael A. Gaul - Officer | Grant or award | Stock Options (Right to buy) | 1,250 | - footnote F1 | - | |
| Michael A. Gaul - Officer | Derivative | Stock Options (Right to buy) | 500 | - footnote F1 | - | |
| Michael A. Gaul - Officer | Grant or award | Stock Options (Right to buy) | 500 | - footnote F1 | - | |
| Michael A. Gaul - Officer | Derivative | Stock Options (Right to buy) | 2,000 | - footnote F1 | - | |
| Michael A. Gaul - Officer | Grant or award | Stock Options (Right to buy) | 2,000 | - footnote F1 | - | |
| Michael A. Gaul - Officer | Derivative | Stock Options (Right to buy) | 20,000 | - footnote F1 | - | |
| Michael A. Gaul - Officer | Grant or award | Stock Options (Right to buy) | 20,000 | - footnote F1 | - | |
| ||||||
| Robert Carey - Director | Derivative | Stock Options (Right to buy) | 4,500 | - footnote F1 | - | |
| Robert Carey - Director | Grant or award | Stock Options (Right to buy) | 4,500 | - footnote F1 | - | |
| Robert Carey - Director | Derivative | Stock Options (Right to buy) | 2,000 | - footnote F1 | - | |
| Robert Carey - Director | Grant or award | Stock Options (Right to buy) | 2,000 | - footnote F1 | - | |
| Robert Carey - Director | Derivative | Stock Options (Right to buy) | 1,500 | - footnote F1 | - | |
| Robert Carey - Director | Grant or award | Stock Options (Right to buy) | 1,500 | - footnote F1 | - | |
| Robert Carey - Director | Derivative | Stock Options (Right to buy) | 1,250 | - footnote F1 | - | |
| Robert Carey - Director | Derivative | Stock Options (Right to buy) | 1,250 | - footnote F1 | - | |
| Robert Carey - Director | Derivative | Stock Options (Right to buy) | 1,250 | - footnote F1 | - | |
| Robert Carey - Director | Grant or award | Stock Options (Right to buy) | 1,250 | - footnote F1 | - | |
| Robert Carey - Director | Grant or award | Stock Options (Right to buy) | 1,250 | - footnote F1 | - | |
| Robert Carey - Director | Grant or award | Stock Options (Right to buy) | 1,250 | - footnote F1 | - | |
| Robert Carey - Director | Derivative | Stock Options (Right to buy) | 50 | - footnote F1 | - | |
| Robert Carey - Director | Grant or award | Stock Options (Right to buy) | 50 | - footnote F1 | - | |
| Robert Carey - Director | Derivative | Stock Options (Right to buy) | 10,000 | - footnote F1 | - | |
| Robert Carey - Director | Grant or award | Stock Options (Right to buy) | 10,000 | - footnote F1 | - | |
| ||||||
| Erick Lucera - Director | Grant or award | Stock Options (Right to buy) | 2,000 | - footnote F1 | - | |
| Erick Lucera - Director | Derivative | Stock Options (Right to buy) | 1,500 | - footnote F1 | - | |
| Erick Lucera - Director | Grant or award | Stock Options (Right to buy) | 1,500 | - footnote F1 | - | |
| Erick Lucera - Director | Derivative | Stock Options (Right to buy) | 1,250 | - footnote F1 | - | |
| Erick Lucera - Director | Derivative | Stock Options (Right to buy) | 1,250 | - footnote F1 | - | |
| Erick Lucera - Director | Derivative | Stock Options (Right to buy) | 1,250 | - footnote F1 | - | |
| Erick Lucera - Director | Grant or award | Stock Options (Right to buy) | 1,250 | - footnote F1 | - | |
| Erick Lucera - Director | Grant or award | Stock Options (Right to buy) | 1,250 | - footnote F1 | - | |
| Erick Lucera - Director | Grant or award | Stock Options (Right to buy) | 1,250 | - footnote F1 | - | |
| Erick Lucera - Director | Derivative | Stock Options (Right to buy) | 1,000 | - footnote F1 | - | |
| Erick Lucera - Director | Grant or award | Stock Options (Right to buy) | 1,000 | - footnote F1 | - | |
| Erick Lucera - Director | Derivative | Stock Options (Right to buy) | 3,750 | - footnote F1 | - | |
| Erick Lucera - Director | Grant or award | Stock Options (Right to buy) | 3,750 | - footnote F1 | - | |
| Erick Lucera - Director | Derivative | Stock Options (Right to buy) | 2,250 | - footnote F1 | - | |
| Erick Lucera - Director | Grant or award | Stock Options (Right to buy) | 2,250 | - footnote F1 | - | |
| Erick Lucera - Director | Derivative | Stock Options (Right to buy) | 2,000 | - footnote F1 | - | |
| ||||||
| Douglas Quinton Larson - Officer | Derivative | Stock Options (Right to buy) | 1,000 | - footnote F1 | - | |
| Douglas Quinton Larson - Officer | Grant or award | Stock Options (Right to buy) | 1,000 | - footnote F1 | - | |
| Douglas Quinton Larson - Officer | Derivative | Stock Options (Right to buy) | 3,750 | - footnote F1 | - | |
| Douglas Quinton Larson - Officer | Grant or award | Stock Options (Right to buy) | 3,750 | - footnote F1 | - | |
| Douglas Quinton Larson - Officer | Derivative | Stock Options (Right to buy) | 17,500 | - footnote F1 | - | |
| Douglas Quinton Larson - Officer | Grant or award | Stock Options (Right to buy) | 17,500 | - footnote F1 | - | |
| Douglas Quinton Larson - Officer | Derivative | Stock Options (Right to buy) | 15,000 | - footnote F1 | - | |
| Douglas Quinton Larson - Officer | Grant or award | Stock Options (Right to buy) | 15,000 | - footnote F1 | - | |
| Douglas Quinton Larson - Officer | Derivative | Stock Options (Right to buy) | 6,000 | - footnote F1 | - | |
| Douglas Quinton Larson - Officer | Grant or award | Stock Options (Right to buy) | 6,000 | - footnote F1 | - | |
| ||||||
| Robert Scott Goodman - Director | Derivative | Stock Options (Right to buy) | 187 | - footnote F1 | - | |
| Robert Scott Goodman - Director | Derivative | Stock Options (Right to buy) | 187 | - footnote F1 | - | |
| Robert Scott Goodman - Director | Grant or award | Stock Options (Right to buy) | 187 | - footnote F1 | - | |
| Robert Scott Goodman - Director | Grant or award | Stock Options (Right to buy) | 187 | - footnote F1 | - | |
| ||||||
| Steven A. Lisi - Officer | Derivative | Warrants to purchase Common Stock | 164,778 | - footnote F1 | - | |
| Steven A. Lisi - Officer | Grant or award | Warrants to purchase Common Stock | 164,778 | - footnote F1 | - | |
| ||||||
| William P. Forbes - Director | Derivative | Stock Options (Right to buy) | 1,250 | - footnote F1 | - | |
| William P. Forbes - Director | Grant or award | Stock Options (Right to buy) | 1,250 | - footnote F1 | - | |
| William P. Forbes - Director | Grant or award | Stock Options (Right to buy) | 1,250 | - footnote F1 | - | |
| William P. Forbes - Director | Derivative | Stock Options (Right to buy) | 400 | - footnote F1 | - | |
| William P. Forbes - Director | Grant or award | Stock Options (Right to buy) | 400 | - footnote F1 | - | |
| William P. Forbes - Director | Derivative | Stock Options (Right to buy) | 1,500 | - footnote F1 | - | |
| William P. Forbes - Director | Grant or award | Stock Options (Right to buy) | 1,500 | - footnote F1 | - | |
| William P. Forbes - Director | Derivative | Stock Options (Right to buy) | 2,000 | - footnote F1 | - | |
| William P. Forbes - Director | Grant or award | Stock Options (Right to buy) | 2,000 | - footnote F1 | - | |
| William P. Forbes - Director | Derivative | Stock Options (Right to buy) | 2,250 | - footnote F1 | - | |
| William P. Forbes - Director | Grant or award | Stock Options (Right to buy) | 2,250 | - footnote F1 | - | |
| William P. Forbes - Director | Derivative | Stock Options (Right to buy) | 3,750 | - footnote F1 | - | |
| William P. Forbes - Director | Grant or award | Stock Options (Right to buy) | 3,750 | - footnote F1 | - | |
| William P. Forbes - Director | Derivative | Stock Options (Right to buy) | 1,250 | - footnote F1 | - | |
| William P. Forbes - Director | Derivative | Stock Options (Right to buy) | 1,250 | - footnote F1 | - | |
| William P. Forbes - Director | Grant or award | Stock Options (Right to buy) | 1,250 | - footnote F1 | - | |
| ||||||
| Robert Scott Goodman - Director | Grant or award | Stock Options (Right to buy) | 3,750 | $0.00 | - | |
| Steven A. Lisi - Officer | Open-market purchase | Common Stock | 6,000 | $64.97 | $19K | |
| Douglas Quinton Larson - Officer | Derivative | Stock Options (Right to buy) | 300,000 | - | - | |
| Douglas Quinton Larson - Officer | Grant or award | Stock Options (Right to buy) | 300,000 | - | - | |
| Douglas Quinton Larson - Officer | Derivative | Stock Options (Right to buy) | 120,000 | - | - | |
| Douglas Quinton Larson - Officer | Grant or award | Stock Options (Right to buy) | 120,000 | - | - | |
| Douglas Quinton Larson - Officer | Derivative | Stock Options (Right to buy) | 20,000 | - | - | |
| Douglas Quinton Larson - Officer | Grant or award | Stock Options (Right to buy) | 20,000 | - | - | |
| Douglas Quinton Larson - Officer | Derivative | Stock Options (Right to buy) | 75,000 | - | - | |
| Douglas Quinton Larson - Officer | Grant or award | Stock Options (Right to buy) | 75,000 | - | - | |
| Erick Lucera - Director | Derivative | Stock Options (Right to buy) | 45,000 | - | - | |
| Erick Lucera - Director | Grant or award | Stock Options (Right to buy) | 45,000 | - | - | |
| Erick Lucera - Director | Derivative | Stock Options (Right to buy) | 40,000 | - | - | |
| Erick Lucera - Director | Grant or award | Stock Options (Right to buy) | 40,000 | - | - | |
| Erick Lucera - Director | Derivative | Stock Options (Right to buy) | 30,000 | - | - | |
| Erick Lucera - Director | Grant or award | Stock Options (Right to buy) | 30,000 | - | - | |
| Erick Lucera - Director | Derivative | Stock Options (Right to buy) | 25,000 | - | - | |
| Erick Lucera - Director | Grant or award | Stock Options (Right to buy) | 25,000 | - | - | |
| Erick Lucera - Director | Derivative | Stock Options (Right to buy) | 25,000 | - | - | |
| Erick Lucera - Director | Grant or award | Stock Options (Right to buy) | 25,000 | - | - | |
| Erick Lucera - Director | Derivative | Stock Options (Right to buy) | 20,000 | - | - | |
| Erick Lucera - Director | Grant or award | Stock Options (Right to buy) | 20,000 | - | - | |
| Erick Lucera - Director | Derivative | Stock Options (Right to buy) | 25,000 | - | - | |
| Erick Lucera - Director | Grant or award | Stock Options (Right to buy) | 25,000 | - | - | |
| Yoori Lee - Director | Derivative | Stock Options (Right to buy) | 45,000 | - | - | |
| Yoori Lee - Director | Grant or award | Stock Options (Right to buy) | 45,000 | - | - | |
| Yoori Lee - Director | Derivative | Stock Options (Right to buy) | 40,000 | - | - | |
| Yoori Lee - Director | Grant or award | Stock Options (Right to buy) | 40,000 | - | - | |
| Yoori Lee - Director | Derivative | Stock Options (Right to buy) | 30,000 | - | - | |
| Yoori Lee - Director | Grant or award | Stock Options (Right to buy) | 30,000 | - | - | |
| Yoori Lee - Director | Derivative | Stock Options (Right to buy) | 25,000 | - | - | |
| Yoori Lee - Director | Grant or award | Stock Options (Right to buy) | 25,000 | - | - | |
| Yoori Lee - Director | Derivative | Stock Options (Right to buy) | 25,000 | - | - | |
| Yoori Lee - Director | Grant or award | Stock Options (Right to buy) | 25,000 | - | - | |
| Yoori Lee - Director | Derivative | Stock Options (Right to buy) | 15,000 | - | - | |
| Yoori Lee - Director | Grant or award | Stock Options (Right to buy) | 15,000 | - | - | |
| Yoori Lee - Director | Derivative | Stock Options (Right to buy) | 25,000 | - | - | |
| Yoori Lee - Director | Grant or award | Stock Options (Right to buy) | 25,000 | - | - | |
| Steven A. Lisi - Officer | Derivative | Stock Options (Right to buy) | 950,000 | - | - | |
| Steven A. Lisi - Officer | Grant or award | Stock Options (Right to buy) | 950,000 | - | - | |
| Steven A. Lisi - Officer | Derivative | Stock Options (Right to buy) | 800,000 | - | - | |
| Steven A. Lisi - Officer | Grant or award | Stock Options (Right to buy) | 800,000 | - | - | |
| Steven A. Lisi - Officer | Derivative | Stock Options (Right to buy) | 280,000 | - | - | |
| Steven A. Lisi - Officer | Grant or award | Stock Options (Right to buy) | 280,000 | - | - | |
| Steven A. Lisi - Officer | Derivative | Stock Options (Right to buy) | 200,000 | - | - | |
| Steven A. Lisi - Officer | Grant or award | Stock Options (Right to buy) | 200,000 | - | - | |
| Steven A. Lisi - Officer | Derivative | Stock Options (Right to buy) | 70,000 | - | - | |
| Steven A. Lisi - Officer | Grant or award | Stock Options (Right to buy) | 70,000 | - | - | |
| Steven A. Lisi - Officer | Derivative | Stock Options (Right to buy) | 250,000 | - | - | |
| Steven A. Lisi - Officer | Grant or award | Stock Options (Right to buy) | 250,000 | - | - | |
| Steven A. Lisi - Officer | Derivative | Stock Options (Right to buy) | 400,000 | - | - | |
| Steven A. Lisi - Officer | Grant or award | Stock Options (Right to buy) | 400,000 | - | - | |
| Robert Carey - Director | Derivative | Stock Options (Right to buy) | 90,000 | - | - | |
| Robert Carey - Director | Grant or award | Stock Options (Right to buy) | 90,000 | - | - | |
| Robert Carey - Director | Derivative | Stock Options (Right to buy) | 40,000 | - | - | |
| Robert Carey - Director | Grant or award | Stock Options (Right to buy) | 40,000 | - | - | |
| Robert Carey - Director | Derivative | Stock Options (Right to buy) | 30,000 | - | - | |
| Robert Carey - Director | Grant or award | Stock Options (Right to buy) | 30,000 | - | - | |
| Robert Carey - Director | Derivative | Stock Options (Right to buy) | 25,000 | - | - | |
| Robert Carey - Director | Grant or award | Stock Options (Right to buy) | 25,000 | - | - | |
| Robert Carey - Director | Derivative | Stock Options (Right to buy) | 25,000 | - | - | |
| Robert Carey - Director | Grant or award | Stock Options (Right to buy) | 25,000 | - | - | |
| Robert Carey - Director | Derivative | Stock Options (Right to buy) | 1,000 | - | - | |
| Robert Carey - Director | Grant or award | Stock Options (Right to buy) | 1,000 | - | - | |
| Robert Carey - Director | Derivative | Stock Options (Right to buy) | 25,000 | - | - | |
| Robert Carey - Director | Grant or award | Stock Options (Right to buy) | 25,000 | - | - | |
| Michael A. Gaul - Officer | Derivative | Stock Options (Right to buy) | 350,000 | - | - | |
| Michael A. Gaul - Officer | Grant or award | Stock Options (Right to buy) | 350,000 | - | - | |
| Michael A. Gaul - Officer | Derivative | Stock Options (Right to buy) | 170,000 | - | - | |
| Michael A. Gaul - Officer | Grant or award | Stock Options (Right to buy) | 170,000 | - | - | |
| Michael A. Gaul - Officer | Derivative | Stock Options (Right to buy) | 70,000 | - | - | |
| Michael A. Gaul - Officer | Grant or award | Stock Options (Right to buy) | 70,000 | - | - | |
| Michael A. Gaul - Officer | Derivative | Stock Options (Right to buy) | 25,000 | - | - | |
| Michael A. Gaul - Officer | Grant or award | Stock Options (Right to buy) | 25,000 | - | - | |
| Michael A. Gaul - Officer | Derivative | Stock Options (Right to buy) | 10,000 | - | - | |
| Michael A. Gaul - Officer | Grant or award | Stock Options (Right to buy) | 10,000 | - | - | |
| Michael A. Gaul - Officer | Derivative | Stock Options (Right to buy) | 40,000 | - | - | |
| Michael A. Gaul - Officer | Grant or award | Stock Options (Right to buy) | 40,000 | - | - | |
| William P. Forbes - Director | Derivative | Stock Options (Right to buy) | 25,000 | - | - | |
| William P. Forbes - Director | Grant or award | Stock Options (Right to buy) | 25,000 | - | - | |
| William P. Forbes - Director | Derivative | Stock Options (Right to buy) | 8,000 | - | - | |
| William P. Forbes - Director | Grant or award | Stock Options (Right to buy) | 8,000 | - | - | |
| William P. Forbes - Director | Derivative | Stock Options (Right to buy) | 25,000 | - | - | |
| William P. Forbes - Director | Grant or award | Stock Options (Right to buy) | 25,000 | - | - | |
| William P. Forbes - Director | Derivative | Stock Options (Right to buy) | 25,000 | - | - | |
| William P. Forbes - Director | Grant or award | Stock Options (Right to buy) | 25,000 | - | - | |
| William P. Forbes - Director | Derivative | Stock Options (Right to buy) | 30,000 | - | - | |
| William P. Forbes - Director | Grant or award | Stock Options (Right to buy) | 30,000 | - | - | |
| William P. Forbes - Director | Derivative | Stock Options (Right to buy) | 40,000 | - | - | |
| William P. Forbes - Director | Grant or award | Stock Options (Right to buy) | 40,000 | - | - | |
| William P. Forbes - Director | Derivative | Stock Options (Right to buy) | 45,000 | - | - | |
| William P. Forbes - Director | Grant or award | Stock Options (Right to buy) | 45,000 | - | - | |
| Ron Bentsur - Director | Derivative | Stock Options (Right to buy) | 45,000 | - | - | |
| Ron Bentsur - Director | Grant or award | Stock Options (Right to buy) | 45,000 | - | - | |
| Ron Bentsur - Director | Derivative | Stock Options (Right to buy) | 40,000 | - | - | |
| Ron Bentsur - Director | Grant or award | Stock Options (Right to buy) | 40,000 | - | - | |
| Ron Bentsur - Director | Derivative | Stock Options (Right to buy) | 30,000 | - | - | |
| Ron Bentsur - Director | Grant or award | Stock Options (Right to buy) | 30,000 | - | - | |
| Ron Bentsur - Director | Derivative | Stock Options (Right to buy) | 25,000 | - | - | |
| Ron Bentsur - Director | Grant or award | Stock Options (Right to buy) | 25,000 | - | - | |
| Ron Bentsur - Director | Derivative | Stock Options (Right to buy) | 25,000 | - | - | |
| Ron Bentsur - Director | Grant or award | Stock Options (Right to buy) | 25,000 | - | - | |
| Ron Bentsur - Director | Derivative | Stock Options (Right to buy) | 24,000 | - | - | |
| Ron Bentsur - Director | Grant or award | Stock Options (Right to buy) | 24,000 | - | - | |
| Robert Carey - Director | Open-market purchase | Common Stock | 1,476,626 | $201.72 | $745K | |
| Robert Carey - Director | Open-market purchase | Pre-funded Warrants to purchase Common Stock | 26,142 | - | - | |
| Robert Carey - Director | Open-market purchase | Pre-funded Warrants to purchase Common Stock | 480,179 | - | - | |
| Robert Carey - Director | Open-market purchase | Warrants to purchase Common Stock | 102,382 | - | - | |
| Robert Carey - Director | Open-market purchase | Warrants to purchase Common Stock | 1,880,565 | - | - | |
| Robert Carey - Director | Other | Warrants to purchase Common Stock | 9,886,633 | - | - | |
| Steven A. Lisi - Officer | Open-market purchase | Common Stock | 1,476,626 | $201.72 | $745K | |
| Steven A. Lisi - Officer | Open-market purchase | Pre-funded Warrants to purchase Common Stock | 506,321 | - | - | |
| Steven A. Lisi - Officer | Open-market purchase | Warrants to purchase Common Stock | 1,982,947 | - | - | |
| Steven A. Lisi - Officer | Other | Warrants to purchase Common Stock | 3,295,544 | - | - | |
Item 2.02, 7.01, 9.01
Item 1.01, 5.02, 9.01
Item 2.02, 7.01, 9.01
Item 8.01
XAIR insider trading FAQ
What is the latest insider trade for XAIR?
Beyond Air, Inc. (XAIR) had 2 insider filings in the last 90 days, with the most recent on 14 October 2026. The full record for XAIR runs to 25 Form 4 filings, the earliest from 2 October 2024. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying XAIR stock?
4 insider purchases of XAIR were filed in the last 90 days, totaling $62K.
How many insiders are selling XAIR stock?
No insider sales of XAIR were filed in the last 90 days.
Where can I see XAIR SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects XAIR Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Yi-Chien Lin view on EDGAR
- - Yi-Chien Lin view on EDGAR
- - Robert Scott Goodman view on EDGAR
- - Daniel J. Moorhead view on EDGAR
- - Daniel J. Moorhead view on EDGAR
- - Yoori Lee view on EDGAR
- - Michael A. Gaul view on EDGAR
- - Robert Carey view on EDGAR
- - Erick Lucera view on EDGAR
Related companies with recent insider activity
Learn more
- How to read insider buying signals
- What an open-market purchase by an insider can and cannot tell you.
- Insider activity in Health Care
- Where XAIR's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow XAIR with a 7-day demo
- XAIR on your watchlist
- Every XAIR Form 4 filing on record
- Up to 3 months of XAIR price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
